A £1.65 million treatment has been approved for use for some NHS patients, offering some with an inherited blood disorder ...

A research group led by Wei Li at the Chinese Academy of Sciences has created mice born from two male parents and capable of ...

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good ...

A new gene editing treatment has been approved for use in the NHS, which will help treat sickle cell disease patients ...

NHS officials estimate that around 50 people a year will receive treatment now that it has been approved for use for certain ...

NHS patients with sickle cell disease will be able to benefit from a groundbreaking gene-editing treatment that offers the prospect of a cure for the condition. The one-off gene therapy, known as ...

A team from UNIGE, the Max Planck Institute for Molecular Physiology in Dortmund, and Heinrich Heine University in Düsseldorf ...

Around 1,700 people could be eligible for the one-time treatment, which is seen as a less risky alternative to a donor stem ...

The UK has approximately 17,500 individuals living with sickle cell disease, a condition particularly prevalent amongst those ...

The treatment uses gene-editing tool Crispr, which earned its inventors the Nobel Prize in chemistry in 2020. Casgevy, also known as exa-cel, was the first treatment to be licensed using gene ...

Casgevy, also known as exa-cel, was the first treatment to be licensed using gene-editing tool Crispr, which earned its inventors the Nobel Prize for chemistry in 2020. It works by editing the fau ...